1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Outcomes with ASA plus clopidogrel versus ASA plus ticagrelor
Outcome ASA + Clopidogrel % (95% CI) I² ASA + Ticagrelor (95% CI) I² P Value
Thromboembolic complications 9.2 (4.7–14.8) 88 5.4 (1.7–10.9) 0 .513
Hemorrhagic complications 5.5 (2.8–9.1) 79 2.5 (0–10.5) 65 .321
Perioperative mortality related to antiplatelet medication 1.2 (0.6–1.9) 0 2.4 (0.02–8.5) 47 .583
Good clinical outcomes 93.0 (87.0–97.2) 85 93.1 (84.3–98.5) 47 .982

Outcome	ASA + Clopidogrel % (95% CI)	I²	ASA + Ticagrelor (95% CI)	I²	P Value
Thromboembolic complications	9.2 (4.7–14.8)	88	5.4 (1.7–10.9)	0	.513
Hemorrhagic complications	5.5 (2.8–9.1)	79	2.5 (0–10.5)	65	.321
Perioperative mortality related to antiplatelet medication	1.2 (0.6–1.9)	0	2.4 (0.02–8.5)	47	.583
Good clinical outcomes	93.0 (87.0–97.2)	85	93.1 (84.3–98.5)	47	.982